May 28, 2014 5:20 pm

The regulators were right to force Pfizer’s hand

Target shareholders are entitled to expect a short ‘virtual bid’ period, writes Adam Bogdanor

You have viewed your allowance of free articles. If you wish to view more, click the button below.